학술논문

The small HDL particle hypothesis of Alzheimers disease.
Document Type
article
Source
Alzheimers and Dementia. 19(2)
Subject
APOE
HDL
cerebrospinal fluid
cognition
lipidomics
proteomics
Humans
Alzheimer Disease
Apolipoproteins E
Apolipoprotein E4
Brain
Cognition
Amyloid beta-Peptides
Language
Abstract
We propose the hypothesis that small high-density lipoprotein (HDL) particles reduce the risk of Alzheimers disease (AD) by virtue of their capacity to exchange lipids, affecting neuronal membrane composition and vascular and synaptic functions. Concentrations of small HDLs in cerebrospinal fluid (CSF) and plasma were measured in 180 individuals ≥60 years of age using ion mobility methodology. Small HDL concentrations in CSF were positively associated with performance in three domains of cognitive function independent of apolipoprotein E (APOE) ε4 status, age, sex, and years of education. Moreover, there was a significant correlation between levels of small HDLs in CSF and plasma. Further studies will be aimed at determining whether specific components of small HDL exchange across the blood, brain, and CSF barriers, and developing approaches to exploit small HDLs for therapeutic purposes.